Royal Society of Chemistry, Food and Function, 1(10), p. 469-478, 2019
DOI: 10.1039/c8fo02009d
Full text: Unavailable
The flavonoid myricitrin-5-methyl ether is a potential drug candidate as a gastric lipase inhibitor for the treatment of obesity.